Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema.

Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema.

Item
http://www.wikidata.org/entity/Q34139793
Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomyTrends in the Care of Diabetic Macular Edema: Analysis of a National CohortThe Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates.Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1).Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusionTREATMENT PATTERNS AND 2-YEAR VISION OUTCOMES WITH BEVACIZUMAB IN DIABETIC MACULAR EDEMA: An Analysis From a Large U.S. Integrated Health Care System.Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal.Re: Changing Trends in the Management of Diabetic Macular Edema at a Single Institution Over the Past Decade.The Role of Focal Laser in the Anti-Vascular Endothelial Growth Factor Era.Diabetic macular edema, innovative technologies and economic impact: New opportunities for the Lombardy Region healthcare system?Early vitrectomy for dense vitreous hemorrhage in adults with non-traumatic and non-diabetic retinopathy.Short-term effects of intravitreal ranibizumab and bevacizumab administration on 24-h ambulatory blood pressure monitoring recordings in normotensive patients with age-related macular degeneration.A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2).The use of bevacizumab and ranibizumab for branch retinal vein occlusion in medicare beneficiaries.Treatment patterns in diabetic macular edema in Taiwan: a retrospective chart review
P2860

Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema.

Item
http://www.wikidata.org/entity/Q34139793
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical utilization of anti-v ...... on and diabetic macular edema.
@ast
Clinical utilization of anti-v ...... on and diabetic macular edema.
@en
Clinical utilization of anti-v ...... on and diabetic macular edema.
@nl
type
label
Clinical utilization of anti-v ...... on and diabetic macular edema.
@ast
Clinical utilization of anti-v ...... on and diabetic macular edema.
@en
Clinical utilization of anti-v ...... on and diabetic macular edema.
@nl
prefLabel
Clinical utilization of anti-v ...... on and diabetic macular edema.
@ast
Clinical utilization of anti-v ...... on and diabetic macular edema.
@en
Clinical utilization of anti-v ...... on and diabetic macular edema.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P932
P356
P1433
P1476
Clinical utilization of anti-v ...... on and diabetic macular edema.
@en
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P932